Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Non-Current Debt (2021 - 2025)

Historic Non-Current Debt for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $1.1 billion.

  • Core Scientific's Non-Current Debt rose 12313.86% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 12313.86%. This contributed to the annual value of $1.1 billion for FY2024, which is 5699.73% up from last year.
  • As of Q3 2025, Core Scientific's Non-Current Debt stood at $1.1 billion, which was up 12313.86% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Non-Current Debt registered a high of $1.1 billion during Q4 2024, and its lowest value of $45000.0 during Q2 2023.
  • For the 5-year period, Core Scientific's Non-Current Debt averaged around $749.3 million, with its median value being $684.1 million (2023).
  • In the last 5 years, Core Scientific's Non-Current Debt crashed by 9999.47% in 2023 and then soared by 117046888.89% in 2024.
  • Core Scientific's Non-Current Debt (Quarter) stood at $652.2 million in 2021, then surged by 30.68% to $852.3 million in 2022, then dropped by 19.74% to $684.1 million in 2023, then skyrocketed by 57.0% to $1.1 billion in 2024, then decreased by 1.4% to $1.1 billion in 2025.
  • Its Non-Current Debt stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $1.1 billion for Q1 2025.